 randomized comparative study prophylactic use trimethoprim-sulfamethoxazole versus netilmycin-metronidazole transrectal prostatic biopsy open randomized study prophylactic value single doses netilmycin-metronidazole versus trimethoprim-sulfamethoxazole prevention postoperative infections transrectal prostatic biopsy patients study patients netilmycin-metronidazole trimethoprim-sulfamethoxazole bacteremia rate netilmycin-metronidazole group patients confidence interval trimethoprim-sulfamethoxazole group confidence interval None patients bacteremia symptomatic Urinary tract infection rates netilmycin-metronidazole group patients trimethoprim-sulfamethoxazole group Trimethoprim-sulfamethoxazole cotrimoxazole choice antimicrobial prophylaxis patients undergoing transrectal prostatic biopsy